Acetyl- L-Carnitine, Alzheimer's disease -

Acetyl-l-carnitine delays the mitochondrial decay of aging and improves cognitive function in Alzheimers disease.

Delaying the mitochondrial decay of aging with  acetylcarnitine

NCBI Public Medical Research 2004:  15591008

Bruce N Ames, Jiankang Liu

CONCLUSION: A recent meta-​-analysis of 21 double-​-blind clinical trials of acetyl carnitine in the treatment of mild cognitive impairment and mild Alzheimer's disease showed significant efficacy vs. placebo. A meta-​-analysis of 4 clinical trials of LA for treatment of neuropathic deficits in diabetes showed significant efficacy vs. placebo. 


NO RISK GUARANTEE

We are so confident in the quality of our formulation. If you are not 100% satisfied we offer a full refund.

SIGN UP TO ONNOR

Receive Early Access to Special Deals, Announcements and New Formulas